230 related articles for article (PubMed ID: 2039199)
1. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.
Iwahi T; Satoh H; Nakao M; Iwasaki T; Yamazaki T; Kubo K; Tamura T; Imada A
Antimicrob Agents Chemother; 1991 Mar; 35(3):490-6. PubMed ID: 2039199
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.
Nakao M; Tada M; Tsuchimori K; Uekata M
Eur J Clin Microbiol Infect Dis; 1995 May; 14(5):391-9. PubMed ID: 7556227
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.
Nakao M
J Clin Gastroenterol; 1995; 20 Suppl 1():S32-7. PubMed ID: 7673612
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori.
Nakao M; Malfertheiner P
Helicobacter; 1998 Mar; 3(1):21-7. PubMed ID: 9546114
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal activity of lansoprazole and omeprazole against Helicobacter pylori in vitro.
Vogt K; Hahn H
Arzneimittelforschung; 1998 Jun; 48(6):694-7. PubMed ID: 9689430
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of ebrotidine, ranitidine, omeprazole, lansoprazole, and bismuth citrate against clinical isolates of Helicobacter pylori.
Alarcón T; Domingo D; Sánchez I; Sanz JC; Martínez MJ; López-Brea M
Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):275-7. PubMed ID: 9707312
[TBL] [Abstract][Full Text] [Related]
7. Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study.
Malizia T; Tejada M; Marchetti F; Favini P; Pizzarelli G; Campa M; Senesi S
J Antimicrob Chemother; 1998 Mar; 41 Suppl B():29-35. PubMed ID: 9579710
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of rabeprazole, a novel proton pump inhibitor, and its thioether derivative alone and in combination with other antimicrobials against recent clinical isolates of Helicobacter pylori.
Kawakami Y; Akahane T; Yamaguchi M; Oana K; Takahashi Y; Okimura Y; Okabe T; Gotoh A; Katsuyama T
Antimicrob Agents Chemother; 2000 Feb; 44(2):458-61. PubMed ID: 10639386
[TBL] [Abstract][Full Text] [Related]
9. Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitro.
Midolo PD; Turnidge JD; Lambert JR; Bell JM
Antimicrob Agents Chemother; 1996 Jun; 40(6):1531-3. PubMed ID: 8726032
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory activities of lansoprazole against respiration in Helicobacter pylori.
Nagata K; Sone N; Tamura T
Antimicrob Agents Chemother; 2001 May; 45(5):1522-7. PubMed ID: 11302821
[TBL] [Abstract][Full Text] [Related]
11. Lansoprazole reverses Helicobacter pylori-inhibited gastric epithelial cell growth.
Nakajima N; Kuwayama H; Iwasaki A; Arakawa Y
J Clin Gastroenterol; 1995; 20 Suppl 2():S90-2. PubMed ID: 7594352
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease.
Nagata K; Takagi E; Tsuda M; Nakazawa T; Satoh H; Nakao M; Okamura H; Tamura T
Antimicrob Agents Chemother; 1995 Feb; 39(2):567-70. PubMed ID: 7726537
[TBL] [Abstract][Full Text] [Related]
13. [In vitro susceptibilities of Helicobacter pylori strains from children to proton pump inhibitors and its thioether derivative].
Taneike I; Tamura Y; Shimizu T; Yamashiro Y; Toyoda S; Yamamoto T
Kansenshogaku Zasshi; 2000 Jul; 74(7):601-2. PubMed ID: 10965666
[No Abstract] [Full Text] [Related]
14. In-vitro activity of lansoprazole against Helicobacter pylori.
Figura N; Crabtree JE; Dattilo M
J Antimicrob Chemother; 1997 May; 39(5):585-90. PubMed ID: 9184356
[TBL] [Abstract][Full Text] [Related]
15. A novel action of the proton pump inhibitor rabeprazole and its thioether derivative against the motility of Helicobacter pylori.
Tsutsui N; Taneike I; Ohara T; Goshi S; Kojio S; Iwakura N; Matsumaru H; Wakisaka-Saito N; Zhang HM; Yamamoto T
Antimicrob Agents Chemother; 2000 Nov; 44(11):3069-73. PubMed ID: 11036024
[TBL] [Abstract][Full Text] [Related]
16. Combined activity of azithromycin and lansoprazole against Helicobacter pylori.
Trautmann M; Riediger C; Möricke A; Vogt K; Bohr U; Glasbrenner B
Helicobacter; 1999 Jun; 4(2):113-20. PubMed ID: 10382125
[TBL] [Abstract][Full Text] [Related]
17. Suppression of Acid Secretion by Lansoprazole and its Effects on Helicobacter pylori. II. Poster presentations from the 2nd International Colloquium on Proton Pump Inhibitors. Houston, Texas, September 29, 1994.
J Clin Gastroenterol; 1995; 20 Suppl 2():S1-135. PubMed ID: 7594319
[No Abstract] [Full Text] [Related]
18. A proton pump inhibitor, E3810, has antibacterial activity through binding to Helicobacter pylori.
Hirai M; Azuma T; Ito S; Kato T; Kohli Y
J Gastroenterol; 1995 Aug; 30(4):461-4. PubMed ID: 7550855
[TBL] [Abstract][Full Text] [Related]
19. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells.
Nagata K; Satoh H; Iwahi T; Shimoyama T; Tamura T
Antimicrob Agents Chemother; 1993 Apr; 37(4):769-74. PubMed ID: 8494373
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection.
de Boer WA; van Etten RJ; Lai JY; Schneeberger PM; van de Wouw BA; Driessen WM
Helicobacter; 1996 Sep; 1(3):145-50. PubMed ID: 9398895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]